Drugs / EuRSV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06216093 | May 2024 → Jul 2025 overdue | respiratory syncytial virus infectious disease | EuBiologics Co.,Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EuRSV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06216093 ↗ |